References
Acheson, G. H., andS. A. Pereira: The blocking effect of tetraethylammonium ion on the superior cervical ganglion of the cat. J. Pharmacol. exp. Ther.87, 273–280 (1946).
—, andJ. Remolina: The temporal course of the effects of postganglionic axotomy on the inferior mesenteric ganglion of the cat. J. Physiol. (Lond.)127, 603–616 (1955).
—, andH. G. Schwarzacher: Correlation between the physiological changes and the morphological changes resulting from axotomy in the inferior mesenteric ganglion of the cat. J. comp. Neurol.106, 247–265 (1956).
Ahlquist, R. P., andB. Levy: Adrenergic receptive mechanism of canine ileum. J. Pharmacol. exp. Ther.127, 146–149 (1959).
Ambache, N.: The nicotinic action of substances supposed to be purely smooth muscle stimulating. B. Effect of BaCl2 and pilocarpine on the superior cervical ganglion. J. Physiol. (Lond.)110, 164–172 (1949).
—: Autonomic ganglionic stimulants. Arch. int. Pharmacodyn.97, 427–446 (1954).
—, andA. W. Lessin: Classification of intestinomotor drugs by means of type D botulinum toxin. J. Physiol. (Lond.)127, 449–478 (1955).
—,W. L. M. Perry, andP. A. Robertson: The effect of muscarine on perfused superior cervical ganglia of cats. Brit. J. Pharmacol.11, 442–448 (1956).
Atanackovic, D., A. F. de Schaepdryver, G. R. de Vleeschhouwer, andC. Heymans: Effects of quaternary derivatives of tyramine and dopamine on sino-aortic chemoreceptors. Arch. int. Pharmacodyn.157, 202–206 (1965).
Bacq, Z. M., etA. Simonart: L'action nicotinique de la pilocarpine. Arch. int. Pharmacodyn.60, 218–221 (1938).
Bainbridge, J. G., andD. M. Brown: Ganglion-blocking properties of atropine-like drugs. Brit. J. Pharmacol.15, 147–151 (1960).
Bárány, E. H.: Transient increase in outflow facility after superior cervical ganglionectomy in rabbits. Arch. Ophthal.67, 303–311 (1962).
Bein, J. H., u.R. Meier: Zur pharmakologischen Analyse der Blutdrucksteigerung durch Coramin, Histamin und Nicotin bei der narkotisierten Katze. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.219, 273–283 (1953).
Beleslin, D., B. Radmanović, andV. Varagić: The effect of substance P on the superior cervical ganglion of the cat. Brit. J. Pharmacol.15, 10–13 (1960).
—, andV. Varagić: The effect of substance P on the responses of the isolated guineapig ileum to acetylcholine, nicotine, histamine and 5-hydroxytryptamine. Arch. int. Pharmacodyn.126, 321–327 (1960).
Benelli, G., D. Della Bella, andA. Gandini: Angiotensin and peripheral sympathetic activity. Brit. J. Pharmacol.22, 211–219 (1964).
Benfey, B. G., andD. R. Varma: Inhibition of sympathomimetic effects on the heart. Brit. J. Pharmacol.23, 399–404 (1964).
Beraldo, W. T.: The pressor effect of peptone in the rat. Brit. J. Pharmacol.13, 178–183 (1958).
—, andA. Zanotto: A ganglion-stimulating principle present in peptone. Brit. J. Pharmacol.15, 224–229 (1960).
Birks, R., B. Katz, andR. Miledi: Physiological and structural changes at the amphibian myoneural junction in the course of nerve degeneration. J. Physiol. (Lond.)150, 145–168 (1960).
Birmingham, A. T., andA. B. Wilson: An analysis of the blocking action of dimethylphenylpiperazinium iodide on the inhibition of isolated small intestine produced by stimulation of the sympathetic nerves. Brit. J. Pharmacol.24, 375–386 (1965).
Bishop, G. H., andP. Heinbecker: A functional analysis of the cervical sympathetic nerve supply to the eye. Amer. J. Physiol.100, 519–532 (1932).
Bokri, E., O. Fehér, andG. Mózsik: Investigation of denervation supersensitivity in a sympathetic ganglion. Pflügers Arch. ges. Physiol.277, 347–356 (1963).
Boura, A. L. A., andA. F. Green: The action of bretylium: adrenergic neurone blocking and other effects. Brit. J. Pharmacol.14, 536–548 (1959).
—,F. C. Copp, W. G. Duncombe, A. F. Green, andA. McCoubrey: The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves. Brit. J. Pharmacol.15, 265–270 (1960).
Bovet-Nitti, F., R. Kohn, M. Marotta, W. P. Scognamiglio, andB. Silvestrini: Histamine induced modification of neuromuscular blockade by lepto- and pachycurares. Arch. int. Pharmacodyn.149, 308–317 (1964).
Bradley, P. B., B. N. Dhawan, andJ. H. Wolstencroft: Pharmacological properties of cholinoceptive neurones in the medulla and pons of the cat. J. Physiol. (Lond.)183, 658–674 (1966).
Brown, G. L., andW. Feldberg: Differential paralysis of the superior cervical ganglion. J. Physiol. (Lond.)86, 10P-11P (1936).
—, andJ. E. Pascoe: Conduction through the inferior mesenteric ganglion of the rabbit. J. Physiol. (Lond.)118, 113–123 (1952).
——: The effect of degenerative section of ganglionic axons on transmission through the ganglion. J. Physiol. (Lond.)123, 565–573 (1954).
Brownlee, G., andJ. Harry: Some pharmacological properties of the circular and longitudinal muscle strips from the guinea-pig isolated ileum. Brit. J. Pharmacol.21, 544–554 (1963).
Brücke, F. T. von: The cholinesterase in sympathetic ganglia. J. Physiol. (Lond.)89, 429–437 (1937).
Bülbring, E.: The action of adrenaline on transmission in the superior cervical ganglion. J. Physiol. (Lond.)103, 55–67 (1944).
—, andJ. H. Burn: An action of adrenaline on transmission in sympathetic ganglia, which may play a part in shock. J. Physiol. (Lond.)101, 289–303 (1942).
Burn, J. H., andH. H. Dale: The vaso-dilator action of histamine, and its physiological significance. J. Physiol. (Lond.)61, 185–214 (1926).
Castro, F. de: Aspects anatomiques de la transmission synaptique ganglionnaire chez les mammifères. Arch. int. Physiol.59, 479–513, (1951).
Chen, G., R. Portman, andA. Wickel: Pharmacology of 1,1-dimethyl-4-phenylpiperazinium iodide, a ganglion-stimulating agent. J. Pharmacol. exp. Ther.103, 330–336 (1951).
Chien, S.: Sensitization of denervated superior cervical ganglia to ACh. Fed. Proc.17, 25 (1958).
Chou, T. C., andF. J. de Elio: The anticurare activity of eserine on the superior cervical ganglion of the cat. Brit. J. Pharmacol.3, 113–115 (1948).
Cohen, L. H., andP. B. Hagen: A physiological role for the presynaptic localization of acetylcholinesterase and for its inhibition by excess substrate. Canad. J. Physiol.42, 593–594 (1964).
Collier, H. O. J., G. W. L. James, andP. J. Piper: Intensification by adrenalectomy or by β-adrenergic blockade of the bronchoconstrictor action of bradykinin in the guinea-pig. J. Physiol. (Lond.)180, 13P-14P (1965).
Coppée, G., etZ. M. Bacq: Dégénérescence, conduction et transmission synaptique dans le sympathique cervical. Arch. int. Physiol.47, 312–320 (1938).
Costa, E., A. M. Revzin, R. Kuntzman, S. Spector, andB. B. Brodie: Role for ganglionic norepinephrine in sympathetic synaptic transmission. Science133, 1822–1823 (1961).
Cragg, B. G.: Failure of conduction and of synaptic transmission in degenerating mammalian C fibers. J. Physiol. (Lond.)179, 95–112 (1965).
Curtis, D. R., andR. W. Ryall: Nicotinic and muscarinic receptors of Renshaw cells. Nature (Lond.)203, 652–653 (1964).
Cuthbert, M. F.: Relative actions of quaternary methyl derivatives of tyramine, dopamine and noradrenaline. Brit. J. Pharmacol.23, 55–65 (1964).
Dale, H. H.: The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. exp. Ther.6, 147–190 (1914).
—, andP. P. Laidlaw: The significance of the suprarenal capsules in the action of certain alkaloids. J. Physiol. (Lond.)45, 1–26 (1912).
Davidovich, A., andJ. V. Luco: The synaptic transmission of sympathetic ganglia during Wallerian degeneration. Effect of length of degenerating nerve fibers. Acta physiol. lat.-amer.6, 49–59 (1956).
De Groat, W. C., andR. I. Volle: Ganglionic actions of oxotremorine. Life Sci.8, 618–623 (1963).
—, andR. L. Volle: The actions of the catecholamines on transmission in the superior ceryical ganglion of the cat. J. Pharmacol. exp. Ther.154, 1–13 (1966a).
——: Interactions between the catecholamines and ganglionic stimulating agents in sympathetic ganglia. J. Pharmacol. exp. Ther.154, 200–215 (1966b).
Del Castillo, J., andB. Katz: Interaction at end-plate receptors between different choline derivatives. Proc. roy. Soc. B146, 369–381 (1957).
Dirnhuber, P., andH. Collumbine: The effect of anticholinesterase agents on the rat's blood pressure. Brit. J. Pharmacol.10, 12–15 (1955).
Dixon, W. E., u.F. Ransom: Pilocarpin, Physostigmin, Arecolin. Gifte, welche bestimmte Nervenendigungen erregen. Handb. exp. Pharmak.2, 746–816 (1924).
Douglas, W. W., andA. M. Poisner: Preferential release of adrenaline from the adrenal medulla by muscarine and pilocarpine. Nature (Lond.)208, 1102–1103 (1965).
—, andJ. M. Ritchie: On excitation of non-medullated afferent fibres in the vagus and aortic nerves by pharmacological means. J. Physiol. (Lond.)138, 31–43 (1957).
Dudel, J.: Facilitatory effects of 5-hydroxytryptamine on the crayfish neuromuscular junction. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.249, 515–528 (1965).
Eccles, J. C.: The action potential of the superior cervical ganglion. J. Physiol. (Lond.)85, 179–206 (1935).
Eccles, R. M.: The effect of nicotine on synaptic transmission in the sympathetic ganglion. J. Pharmacol. exp. Ther.118, 26–38 (1956).
—, andB. Libet: Origin and blockade of the synaptic responses of curarized sympathetic ganglia. J. Physiol. (Lond.)157, 484–503 (1961).
Elliott, R. C.: Centrally active drugs and transmission through the isolated superior cervical ganglion of the rabbit when stimulated repetitively. Brit. J. Pharmacol.24, 76–88 (1965).
Emmelin, N., andB. C. R. Strömblad: A “paroxysmal” secretion of saliva following parasympathetic denervation of the parotid gland. J. Physiol. (Lond.)143, 506–514 (1958).
Eränkö, O., andM. Härkönen: Monoamine-containing small cells in the superior cervical ganglion of the rat and an organ composed of them. Acta physiol. scand.63, 511–512 (1965).
Euler, U. S. von, andB. Domeij: Nicotine-like actions of arecoline. Acta pharmacol. (Kbh.)1, 263–269 (1945).
Exley, K. A.: The blocking action of choline 2:6-xylyl ether bromide on adrenergic nerves. Brit. J. Pharmacol.12, 297–305 (1957).
Fastier, F. N., M. A. McDowall, andH. Waal: Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine. Brit. J. Pharmacol.14, 527–535 (1959).
Fehér, O., u.E. Bokri: Über die Rolle der Cholinesterase im Prozeß der ganglionären Erregungsübertragung. Pflügers Arch. ges. Physiol.269, 55–67 (1959a).
——: Über die Acetylcholinreceptoren der sympathischen Ganglien. Pflügers Arch. ges. Physiol.269, 68–76 (1959b).
Feldberg, W.: The action of bee venom, cobra venom and lysolecithin on the adrenal medulla. J. Physiol. (Lond.)99, 104–118 (1940).
—: Synthesis of acetylcholine in sympathetic ganglia and cholinergic nerves. J. Physiol. (Lond.)101, 432–445 (1943).
Feldberg, W., andG. P. Lewis: The action of peptides on the adrenal medulla. Release of adrenaline by bradykinin and angiotensin. J. Physiol. (Lond.)171, 98–108 (1964).
——: Further studies on the effects of peptides on the suprarenal medulla of c cats. J. Physiol. (Lond.)178, 239–251 (1965).
—,B. Minz, andH. Tsudzimura: The mechanism of the nervous discharge of adrenaline. J. Physiol. (Lond.)81, 286–304 (1934).
—, andA. Vartiainen: Futher observations on the physiology and pharmacology of a sympathetic ganglion. J. physiol. (Lond.)83, 103–128 (1935).
Flacke, W., andR. A. Gillis: Muscarinic ganglionic transmission. Pharmacologist8, 193 (1966).
Fleckenstein, A., andJ. H. Burn: The effect of denervation on the action of sympathomimetic amines on the nictitating membrane. Brit. J. Pharmacol.8, 69–78 (1953).
—, u.D. Stöckle: Zum Mechanismus der Wirkungsverstärkung und Wirkungsabschwächung sympathomimetischer Amine durch Cocain und andere Pharmaka. II. Die Hemmung der Neuro-Sympathomimetica durch Cocain. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.224, 401–415 (1955).
Folkow, B., B. Johansson, andB. Öberg: The stimulation threshold of different sympathetic fiber groups as correlated to their functional differentiation. Acta physiol. scand.44, 146–156 (1958).
Franko, B. V., J. W. Ward, andR. S. Alphin: Pharmacologic studies of N-benzyl-3-pyrrolidyl acetate methobromide (AHR-602), a ganglion stimulating agent. J. Pharmacol. exp. Ther.139, 25–30 (1963).
Fredricsson, B., andF. Sjöqvist: A cytomorphological study of cholinesterase in sympathetic ganglia of the cat. Acta morph. neerl.-scand.5, 140–166 (1962).
Freyburger, W. A., C. C. Gruhzit, B. R. Rennick, andG. K. Moe: Action of tetraethylammonium on pressure response to asphyxia. Amer. J. Physiol.163, 554–560 (1950).
Gaddum, J. H.: Tryptamine receptors. J. Physiol. (Lond.)119, 363–368 (1953).
—, andN. J. Giarman: Preliminary studies on the biosynthesis of 5-HT. Brit. J. Pharmacol.11, 88–92 (1956).
—, andM. K. Paasonen: The use of some molluscan hearts for the estimation of 5-HT. Brit. J. Pharmacol.10, 474–483 (1955).
—, andZ. P. Picarelli: Two kinds of tryptamine receptors. Brit. J. Pharmacol.12, 323–328 (1957).
Gebber, G. L., andR. L. Volle: Mechanisms involved in ganglionic blockade induced by tetramethylammonium. J. Pharmacol. exp. Ther.152, 18–28 (1966).
Gertner, S. B.: The effect of compound 48/80 on ganglionic transmission. Brit. J. Pharmacol.10, 103–109 (1955).
—: The effects of monoamine oxidase inhibitors on ganglionic transmission. J. Pharmacol. exp. Ther.131, 223–230 (1961).
—: Histamine pools in sympathetic ganglia. Pharmacologist7, 153 (1965).
—, andR. Kohn: Effect of histamine on ganglionic transmission. Brit. J. Pharmacol.14, 179–182 (1959).
—,M. K. Paasonen, andN. J. Giarman: Studies concerning the presence of 5-hydroxytryptamine (serotonin) in the perfusate from the superior cervical ganglion. J. Pharmacol. exp. Ther.127, 268–275 (1959).
—, andA. Romano: Action of guanethidine and bretylium on ganglionic transmission. Fed. Proc.20, 319 (1961).
Gibson, W. C.: Degeneration and regeneration of sympathetic synapses. J. Neurophysiol.3, 237–247 (1940).
Ginsborg, B. L.: The actions of McN-A-343, pilocarpine and acetyl-β-methylcholine on sympathetic ganglion cells of the frog. J. Pharmacol. exp. Ther.150, 216–219 (1965).
—, andS. Guerrero: On the action of depolarizing drugs on sympathetic ganglion cells of the frog. J. Physiol. (Lond.)172, 189–206 (1964).
Ginzel, K. H., andS. R. Kottegoda: The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. J. Physiol. (Lond.)123, 277–288 (1954).
Gokhale, S. D., O. D. Gulati, andN. Y. Joshi: Participation of an unusual ganglionic pathway in the mediation of the pressor effect of physostigmine in the rat. Brit. J. Pharmacol.23, 34–42 (1964).
Gold, D., andH. Reinert: The depolarizing and blocking action of some sympathomimetic amines in the cat's superior cervical ganglion. J. Physiol. (Lond.)151, 3P-4P (1960).
Grimson, K. S., A. K. Tarazi, andJ. W. Frazer: A new orally active quaternary ammonium, ganglion blocking drug capable of reducing blood pressure, SU-3088. Circulation11, 733–741 (1955).
Gromadzki, C. G., andG. B. Koelle: The effect of axotomy on the acetylcholinesterase of the superior cervical ganglion of the cat. Biochem. Pharmacol.14, 1745–1754 (1965).
Guth, L.: Functional recovery following vagosympathetic anastomosis in the cat. Amer. J. Physiol.185, 205–208 (1956).
Gyermek, L.: The action of 5-hydroxytryptamine on the urinary bladder of the dog. Pharmacologist2, 89 (1960).
—: 5-Hydroxy-3-indoleacetamidine: a new type of blocking agent against 5-HT. Nature (Lond.)192, 465 (1961).
—: Action of guanidine derivatives on autonomic ganglia. Arch. int. Pharmacodyn.150, 570–581 (1964).
—, andE. Bindler: Blockade of the ganglionic stimulant action of 5-hydroxytryptamine. J. Pharmacol. exp. Ther.135, 344–348 (1962a).
——: Action of indole alkylamines and amidines on the inferior mesenteric ganglion of the cat. J. Pharmacol. exp. Ther.138, 159–164 (1962b).
—, andE. Bindler: Ganglionic stimulant action of muscarine. Amer. J. Physiol.204, 68–70 (1963).
—, u.L. Sztanyik: Die Wirkung des Histamins auf die Nebenniere. Kisérl. Orvostud.4, 1–8 (1952).
—, andK. R. Unna: Relation of structure of synthetic muscarines and muscarones to their pharmacological action. Proc. Soc. exp. Biol. (N.Y.)98, 882–885 (1958).
Hamberger, B., andK. A. Norberg: Studies on some systems of adrenergic synaptic terminals in the abdominal ganglia of the cat. Acta physiol. scand.65, 235–242 (1965).
——, andF. Sjöqvist: Evidence for adrenergic nerve terminals and synapses in sympathetic ganglia. Int. J. Neuropharmacol.2, 279–282 (1964).
——, andU. Ungersted: Adrenergic synaptic terminals in autonomic ganglia. Acta physiol. scand.64, 285–286 (1965).
Hanna, C., P. B. McHugo, andW. H. Macmillan: Cardiovascular actions of histamine and potassium. Amer. J. Physiol.197, 1005–1007 (1959).
Harry, J.: The action of drugs on the circular muscle strip from the guinea pig isolated ileum. Brit. J. Pharmacol.20, 399–417 (1963).
Heaton, T. B., andM. H. MacKeith: On the action of pilocarpine. J. Physiol. (Lond.)63, 42–50 (1927).
Hebb, C. O., andH. Konzett: The effect of certain analgesic drugs on synaptic transmission as observed in the perfused superior cervical ganglion of the cat. Quart. J. exp. Physiol.35, 213–217 (1949).
—, andG. M. H. Waites: Choline acetylase in antero- and retrograde degeneration of a cholinergic nerve. J. Physiol. (Lond.)132, 667–671 (1956).
Herr, F., andL. Gyermek: Action of cholinergic stimulants on the inferior mesenteric ganglion of the cat. J. Pharmacol. exp. Ther.129, 338–342 (1960).
Hertzler, E. C.: 5-Hydroxytryptamine and transmission in sympathetic ganglia. Brit. J. Pharmacol.17, 406–413 (1961).
Heymans, C., etG. van den Heuvel-Heymans: Sur la pharmacologie de l'hydroxy-tryptamine et d'une substance analogue. Arch. int. Pharmacodyn.93, 95–104 (1953).
Hilton, J. G.: The pressor response to neostigmine after ganglionic blockade. J. Pharmacol. exp. Ther.132, 23–28 (1961).
—, andM. Steinberg: Effects of ganglion- and parasympathetic-blocking drugs upon the pressor response elicited by elevation of the intracranial fluid pressure. J. Pharmacol. exp. Ther.153, 285–291 (1966).
Hirschmann, L.: Zur Lehre von der durch Arzneimittel hervorgerufenen Miosis und Mydriasis. Arch. Anat. Physiol.1863, 309–318.
Hoet, J.: Sur les effects de la pilocarpine. Ann. Physiol.4, 714–715 (1928).
Hogben, L. T., W. Schlapp, andA. D. MacDonald: Studies on the pituitary. IV. Quantitative comparison of pressor activity. Quart. J. exp. Physiol.14, 301–318 (1924).
Holaday, D. A., K. Kamijo, andG. B. Koelle: Facilitation of ganglionic transmission following inhibition of cholinesterase by DFP. J. Pharmacol. exp. Ther.111, 241–254 (1954).
Holmstedt, B., andF. Sjöqvist: Distribution of acetocholinesterase in the ganglion cells of various sympathetic ganglia. Acta physiol. scand.47, 284–296 (1959).
Hunt, C. C., andP. G. Nelson: Structural and functional changes in the frog sympathetic ganglion following cutting of the presynaptic nerve fibers. J. Physiol. (Lond.)177, 1–20 (1965).
Hunt, R.: Vasodilator reactions II. Amer. J. Physiol.45, 231–267 (1918).
Iorio, L. C., andR. J. McIsaac: Comparison of the stimulating effects of nicotine, pilocarpine, and histamine on the superior cervical ganglion of the cat. J. Pharmacol. exp. Ther.151, 430–437 (1966).
Jaanus, S. D., andR. P. Rubin: The action of sympathomimetic amines on the adrenal medulla. Pharmacologist7, 168 (1965).
Jacobowitz, D.: Histochemical studies of the autonomic innervation of the gut. J. Pharmacol. exp. Ther.149, 358–364 (1965).
Job, C., andA. Lundberg: Reflex excitation of cells in the inferior mesenteric ganglion on stimulation of the hypogastric nerve. Acta physiol. scand.26, 366–382 (1952).
Jones, A.: Ganglionic actions of muscarinic substances. J. Pharmacol. exp. Ther.141, 195–205 (1963).
—,B. Gomez Alonso de la Sierra, andU. Trendelenburg: The pressor response of the spinal cat to different groups of ganglion-stimulating agents. J. Pharmacol. exp. Ther.139, 312–320 (1963).
Kamijo, K., andG. B. Koelle: The relationship between cholinesterase inhibition and ganglionic transmission. J. Pharmacol. exp. Ther.105, 349–357 (1952).
Kaneko, Y., J. W. McCubbin, andI. H. Page: Ability of vasoconstrictor drugs to cause adrenal medullary discharge after ‘sensitization’ by ganglion stimulating agents. Circulat. Res.9, 1247–1254 (1961).
Kewitz, H.: Zur Bedeutung des Acetylcholins als Überträgersubstanz sympathischer Gangien. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.222, 323–329 (1954).
—, u.H. Reinert: Wirkung verschiedener Sympathicomimetica auf die chemisch und elektrisch ausgelöste Erregung des oberen Halsganglions. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.222, 311–314 (1954).
Kibjakow, A. W.: Über humorale Übertragung der Erregung von einem Neuron auf das andere. Pflügers Arch. ges. Physiol.232, 432–443 (1933).
Koelle, G. B.: Cytological distribution and physiological functions of cholinesterases. Cholinesterases and Anticholinesterase Agents. (Ed.G. B. Koelle). Handbuch der experimentellen Pharmakologie, Erg.-Bd. 15, p. 1220. Berlin-Göttingen-Heidelberg: Springer 1963.
Komalahiranya, A., andR. L. Volle: Actions of inorganic ions and veratrine on asynchronous postganglionic discharge in sympathetic ganglia treated with diisopropyl phosphofluoridate (DFP). J. Pharmacol. exp. Ther.138, 57–65 (1962).
Konzett, H.: Sympathomimetica und Sympathicolytica am isoliert durchströmten Ganglion cervicale superius der Katze. Helv. physiol. pharmacol. Acta8, 245–258 (1950).
—: The effect of histamine on an isolated sympathetic ganglion. J. Mt Sinai Hosp.19, 149–153 (1952).
—, u.E. Rothlin: Beeinflussung der nikotinartigen Wirkung von ACh durch Atropin. Helv. physiol. pharmacol. Acta7, C46 (1949).
——: Die Wirkung synaptotroper Substanzen auf gewisse efferente und afferente Strukturen des autonomen Nervensystems. Experientia (Basel)9, 405 (1953).
—, u.P. G. Waser: Zur ganglionären Wirkung von Muskarin. Helv. physiol. pharmacol. Acta14, 202–206 (1956).
Koppanyi, Th.: Studies on the synergism and antagonism of drugs. I. The non-parasympathomimetic antagonism between atropine and the miotic alkaloids. J. Pharmacol. exp. Ther.46, 395–405 (1932).
—: The hemodynamic effect of pilocarpine. J. Pharmacol. exp. Ther.65, 19–20 (1939).
Kosterlitz, H. W., andJ. A. Robinson: Inhibition of the peristaltic reflex of the isolated guinea-pig ileum. J. Physiol. (Lond.)136, 249–262 (1957).
Kristic, M., andV. Varagić: Difference between the blood pressure responses to intrajugular and intracarotid injections of physostigmine, and the syndrome of contralateral torsion in the rat. Brit. J. Pharmacol.24, 132–137 (1965).
Kuntz, A., andG. Saccomanno: Reflex inhibition of intestinal motility mediated through decentralized prevertebral ganglia. J. Neurophysiol.7, 163–170 (1944).
Kuz'mina, S. V.: Structural organization of inferior mesenteric ganglion. Arkh. Anat. Gistol. Embriol.45, 51 (1963); Fed. Proc.23, T706–T710 (1964).
Langer, S. Z.: The degeneration contraction of the nictitating membrane in the unanesthetized cat. J. Pharmacol. exp. Ther.151, 66–72 (1966a).
—: Presence of tone in the denervated and the decentralized nictitating membrane of the spinal cat and its influence on determinations of supersensitivity. J. Pharmacol. exp. Ther.154, 14–34 (1966b).
Langer, S. Z., P. R. Draskóczy, andU. Trendelenburg: Time course of development of super-sensitivity of the denervated or decentralized nictitating membrane of the cat. J. Pharmacol. exp. Ther. in press (1967).
Langley, J. N., andW. L. Dickinson: On the local paralysis of peripheral ganglia, and on the connexion of different classes of nerve fibres with them. Proc. roy. Soc. Series B.46, 423–431 (1889).
Lecomte, J.: Sensibilisation à l'adrénaline par la 5-HT. Arch. int. Physiol.61, 84–85 (1953).
—,J. Troquet etA. Dresse: Stimulation médullo-surrénalienne par la bradykinine. Arch. int. Physiol.69, 89–91 (1961).
Lee, F. L., andU. Trendelenburg: Transmission of preganglionic impulses through the muscarinic receptors of the adrenal medulla of the cat. In preparation, 1967.
Lee, W. C., andF. E. Shideman: The inotropic actions of quaternary ammonium compounds. J. Pharmacol. exp. Ther.127, 219–228 (1959).
Lei, B. W., andG. D. Maengwyn-Davies: Adrenergic receptors in the superior cervical ganglion (SCG) of the cat. Pharmacologist7, 185 (1965).
Levy, B., andR. P. Ahlquist: A study of sympathetic ganglionic stimulants. J. Pharmacol. exp. Ther.137, 219–228 (1962).
Lewis, G. P., andE. Reit: The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J. Physiol. (Lond.)179, 538–553 (1965).
Libet, B.: Slow synaptic responses and excitatory changes in sympathetic ganglia. J. Physiol. (Lond.)174, 1–25 (1964).
Lindell, S. E., H. Westling, andT. White: Release of pressor amines from the adrenal glands of the cat by two histamine analogues. Arch. int. Pharmacodyn.127, 410–412 (1960).
Lindmar, R.: Die Wirkung von 1,1-Dimethyl-4-Phenyl-Piperazinium-Jodid am isolierten Vorhof im Vergleich zur Tyramin- und Nicotinwirkung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.242, 458–466 (1962).
Ling, H. W.: Actions of dimethylphenylpiperazinium. Brit. J. Pharmacol.14, 505–511 (1959).
Long, J. P., andJ. W. Eckstein: Ganglionic actions of neostigmine methylsulfate. J. Pharmacol. exp. Ther.133, 216–222 (1961).
Lundberg, A.: Adrenaline and transmission in the sympathetic ganglion of the cat. Acta physiol. scand.26, 252–263 (1952).
MacIntosh, F. C.: L'effet de la section des fibres préganglionnaires sur la teneur en acétylcholine du ganglion sympathique. Arch. int. Physiol.47, 321–324 (1938).
Macmillan, W. H.: The effect of histamine on skeletal muscle contraction. Arch. int. Pharmacodyn.108, 19–26 (1956).
Malméjac, J.: Action of adrenaline on synaptic transmission and on adrenal medullary secretion. J. Physiol. (Lond.)130, 497–512 (1955).
Marruzzi, A. S.: Electrical studies on the pharmacology of autonomic synapses. I. The action of parasympathomimetic drugs on sympathetic ganglia. J. Pharmacol. exp. Ther.65, 18–35 (1939a).
—: Electrical studies on the pharmacology of autonomic synapses. II. The action of a sympathomimetic drug (epinephrine) on sympathetic ganglia. J. Pharmacol. exp. Ther.65, 395–404 (1939b).
—, andR. N. Marrazzi: Further localization and analysis of adrenergic synaptic inhibition. J. Neurophysiol.10, 165–178 (1947).
Mason, D. F. J.: A ganglion stimulating action of neostigmine. Brit. J. Pharmacol.18, 76–86 (1962a).
—: Depolarizing action of neostigmine at an autonomic ganglion. Brit. J. Pharmacol.18, 572–587 (1962b).
Matsumura, M., andG. B. Koelle: The nature of synaptic transmission in the superior cervical ganglion following reinnervation by the afferent vagus. J. Pharmacol. exp. Ther.134, 28–46 (1961).
Matthews jr.,R. J.: The effect of epinephrine, levarterenol and dl-isoproterenol on transmission in the superior cervical ganglion of the cat. J. Pharmacol. exp. Ther.116, 433–443 (1956).
Maxwell, R. A., A. J. Plummer, S. D. Ross, andM. W. Osborne: Effect of ganglionic blocking agents on pressor responses induced by splanchnic faradization. Proc. Soc. exp. Biol. (N.Y.)92, 225–227 (1956).
McCubbin, J. W., J. H. Green, G. C. Salmoiraghi, andI. H. Page: The chemoreceptor stimulant action of serotonin in dogs. J. Pharmacol. exp. Ther.116, 191–197 (1956).
McKinstry, D. N., E. Koenig, W. A. Koelle, andG. B. Koelle: The release of acetylcholine from a sympathetic ganglion by carbachol. Canad. J. Biochem.41, 2599–2609 (1963).
McLennan, H., andJ. E. Pascoe: The origin of certain non-medullated nerve fibres which form synapses in the inferior mesenteric ganglion of the rabbit. J. Physiol. (Lond.)124, 145–156 (1954).
Mendez, R., andA. Ravin: On the action of prostigmine on the circulatory system. J. Pharmacol. exp. Ther.72, 80–89 (1941).
Moe, G. K., andW. A. Freyburger: Ganglionic blocking agents. Pharmacol. Rev.2, 61–95 (1950).
Murayama, S., andK. R. Unna: Stimulant action of 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343) on sympathetic ganglia. J. Pharmacol. exp. Ther.140, 183–192 (1963).
Murray, J. G., andJ. W. Thompson: Collateral sprouting in response to injury of the autonomic nervous system and its consequences. Brit. med. Bull.13, 213–219 (1957a).
——: The occurrence and function of collateral sprouting in the sympathetic nervous system of the cat. J. Physiol. (Lond.)135, 133–162 (1957b).
Norberg, K. A.: Adrenergic innervation of the intestinal wall studied by fluorescence microscopy. Int. J. neuropharmacol.3, 379–382 (1964).
Page, I. H., andJ. W. McCubbin: The variable arterial pressure response to serotonin in laboratory animals and man. Circulat. Res.1, 354–362 (1953).
Pardo, E. G., J. Cato, E. Gijón, andF. Alonso de Florida: Influence of several adrenergic drugs on synaptic transmission through the superior cervical ganglion and the ciliary ganglion of the cat. J. Pharmacol. exp. Ther.139, 296–303 (1963).
Pascoe, J. E.: The effects of acetylcholine and other drugs on the isolated superior cervical ganglion. J. Physiol. (Lond.)132, 242–255 (1956).
Paton, W. D. M.: Types of pharmacological action at autonomic ganglia. Arch. int. Pharmacodyn.97, 267–281 (1954).
—: The action of morphine and related substances on contraction and on acetylcholineoutput of coaxially stimulated guinea-pig ileum. Brit. J. Pharmacol.12, 119–127 (1957).
—: A theory of drug action based on the rate of drug-receptor combination. Proc. roy. Soc. B154, 21–69 (1961).
—, andW. L. M. Perry: The relationship between depolarization and block in the cat's superior cervical ganglion. J. Physiol. (Lond.)119, 43–57 (1953).
Paton, W. D. M., andJ. W. Thompson: The mechanism of action of adrenaline on the superior cervical ganglion of the cat. XIX. Int. Congress, Montreal, p. 664, 1953.
Pelikan, E. W.: The mechanism of ganglionic blockade produced by nicotine. Ann. N.Y. Acad. Sci.90, 52–69 (1960).
Perry, W. L. M.: Acetylcholine release in the cat's superior cervical ganglion. J. Physiol. (Lond.)119, 439–454 (1953).
—, and H. Reinert: The effects of preganglionic denervation on the reactions of ganglion cells. J. Physiol. (Lond.)126, 101–115 (1954).
——: On the metabolism of normal and denervated sympathetic ganglion cells. J. Physiol. (Lond.)130, 156–166 (1955).
Reas, H. W., andU. Trendelenburg: Denervation supersensitivity of the sweat glands of the cat. J. Pharmacol. exp. Ther. in press (1967).
Reid, G.: Circulatory effects of 5-hydroxytryptamine. J. Physiol. (Lond.)118, 435–453 (1952).
Reinert, H.: The effect of amphetamines on peripheral synaptic structures. In: Neuropsychopharmacology, p. 399–404. Amsterdam: Elsevier Publ. Co. 1959.
—: The depolarizing and blocking action of amphetamine in the cat's superior cervical ganglion. In: Adrenergic Mechanisms, p. 373–379. Boston: Little, Brown & Co. 1960.
—: Role and origin of noradrenaline in the superior cervical ganglion. J. Physiol. (Lond.)167, 18–29 (1963).
Robertson, P. A.: An antagonism of 5-hydroxytryptamine by atropine. J. Physiol. (Lond.)121, 54P-55P (1953).
—: Potentiation of HT by the true cholinesterase inhibitor 284C 51. J. Physiol. (Lond.)125, 37P-38P (1954).
Rocha e Silva, M., J. R. Valle, andZ. P. Picarelli: A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea-pig ileum. Brit. J. Pharmacol.8, 378–388 (1953).
Root, M. A.: Certain aspects of the vasopressor action of pilocarpine. J. Pharmacol. exp. Ther.101, 125–131 (1951).
Rossum, J. M. van: Classification and molecular pharmacology of ganglionic blocking agents. Part I. Mechanism of ganglionic synaptic transmission and mode of action of ganglionic stimulants. Int. J. Neuropharmacol.1, 97–110 (1962).
Roszkowski, A. P.: An unusual type of ganglionic stimulant. J. Pharmacol. exp. Ther.132, 156–170 (1961).
Sakussow, W. W.: Die Wirkung von ganglienblockierenden Substanzen auf visceroviscerale Reflexe. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.236, 156–157 (1959).
Salerno, P. R., andJ. M. Coon: A pharmacologic comparison of hexaethyl tetraphosphate (HETP) and tetraethyl pyrosphosphate (TEPP) with physostigmine, neostigmine and DEP. J. Pharmacol. exp. Ther.95, 240–255 (1949).
Schenk, E. A., andE. G. Anderson: The effect of histamine on neuromyal blocking agents. J. Pharmacol. exp. Ther.122, 234–238 (1958).
Schmiedeberg, O.: Ber. kgl sächs. Ges. Wiss.22, 130 (1870). quoted byW. Heubner: Historische Notiz über die Entdeckung der Synapsen im autonomen Nervensystem mit Hilfe des Nikotins. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.204, 33–35 (1947).
Shand, D. G.: The mode of action of drugs blocking ganglionic transmission in the rat. Brit. J. Pharmacol.24, 89–97 (1965).
Siehe, H. J.: Die Reaktion des denervierten Nebennierenmarkes auf humorale Sekretionsreize. Pflügers Arch. ges. Physiol.234, 204–209 (1934).
Slater, I. H., andP. E. Dresel: The pressor effect of histamine after autonomic ganglionic blockade. J. Pharmacol. exp. Ther.105, 101–107 (1952).
Smith, C. B., U. Trendelenburg, S. Z. Langer, andT. H. Tsai: The relation of retention of norepinephrine-H3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J. Pharmacol. exp. Ther.151, 87–94 (1966).
Smith, J. C.: Observations on the selectivity of stimulant action of 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium chloride on sympathetic ganglia. J. Pharmacol. exp. Ther.153, 266–275 (1966a).
—: Pharmacologic interactions with 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride, a sympathetic ganglion stimulant. J. Pharmacol. exp. Ther.153, 276–284 (1966b).
Staszewska-Barczak, J., andJ. R. Vane: The release of catecholamines from the adrenal medulla by peptides. J. Physiol. (Lond.)177, 57P-58P (1965a).
——: The release of catechol amines from the adrenal medulla by histamine. Brit. J. Pharmacol.25, 728–742 (1965b).
Steward, G. N., andJ. M. Rogoff: The action of drugs upon the output of epinephrine from the adrenals. VII. Physostigmine. J. Pharmacol. exp. Ther.17, 227–248 (1921).
Suden, C. Tum, andA. S. Marrazzi: Synaptic inhibitory action of adrenaline at parasympathetic synapses. Fed. Proc.10, 138 (1951).
Szczygielski, J.: Die adrenalinabsondernde Wirkung des Histamins und ihre Beeinflussung durch Nikotin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.166, 319–332 (1932).
Takeshige, C., A. J. Pappano, W. C. de Groat andR. L. Volle: Ganglionic blockade produced in sympathetic ganglia by cholinomimetic drugs. J. Pharmacol. exp. Ther.141, 333–342 (1963).
—, andR. L. Volle: Bimodal response of sympathetic ganglia to acetylcholine following eserine or repetitive preganglionic stimulation. J. Pharmacol. exp. Ther.138, 66–73 (1962).
——: Asynchronous postganglionic firing from the cat superior cervical sympathetic ganglion treated with neostigmine. Brit. J. Pharmacol.20, 214–220 (1963a).
——: Cholinoceptive sites in denervated sympathetic ganglia. J. Pharmacol. exp. Ther.141, 206–213 (1963b).
——: Modification of ganglionic responses to cholinomimetic drugs following preganglionic stimulation, anticholinesterase agents and pilocarpine. J. Pharmacol. exp. Ther.146, 335–343 (1964a).
——: A comparison of the ganglion potentials and block produced by acetylcholine and tetramethylammonium. Brit. J. Pharmacol.23, 80–89 (1964b).
——: Similarities in the ganglionic actions of calcium ions and atropine. J. Pharmacol. exp. Ther.145, 173–180 (1964c).
Thompson, J. W.: Studies on the response of the isolated nictitating membrane of the cat. J. Physiol. (Lond.)141, 46–72 (1958).
Trendelenburg, P.: Physiologische und pharmakologische Versuche über die Dünndarmperistaltik. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.81, 55–129 (1917).
Trendelenburg, U.: The action of histamine and pilocarpine on the superior cervical ganglion and the adrenal glands of the cat. Brit. J. Pharmacol.9, 481–487 (1954).
—: The potentiation of ganglionic transmission by histamine and pilocarpine. J. Physiol. (Lond.)129, 337–351 (1955).
—: The action of 5-hydroxytryptamine on the nictitating membrane and on the superior cervical ganglion of the cat. Brit. J. Pharmacol.11, 74–80 (1956a).
—: Modification of ganglionic transmission through the superior cervical ganglion of the cat. J. Physiol. (Lond.)132, 529–541 (1956b).
—: The action of histamine, pilocarpine and 5-HT on transmission through the superior cervical ganglion. J. Physiol. (Lond.)135, 66–72 (1957a).
—: The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat. Brit. J. Pharmacol.12, 79–85 (1957b).
—: Reaktion sympathischer Ganglien während der Ganglienblockade durch Nikotin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.230, 448–456 (1957c).
—: Stimulation of sympathetic centres by histamine. Circulat. Res.5, 105–110 (1957d).
—: Non-nicotinic ganglion-stimulating substances. Fed. Proc.18, 1001–1005 (1959).
—: Observations on the mode of action of some non-depolarizing ganglion-blocking substances. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.241, 452–466 (1961a).
—: The pressor response of the cat to histamine and pilocarpine. J. Pharmacol. exp. Ther.131, 65–72 (1961b).
—: The action of acetylcholine on the nictitating membrane of the spinal cat. J. Pharmacol. exp. Ther.135, 39–44 (1962).
—: Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev.15, 225–276 (1963).
—: Observations on the ganglion-stimulating action of angiotensin and bradykinin. J. Pharmacol. exp. Ther.154, 418–425 (1966a).
—: Transmission of preganglionic impulses through the muscarinic receptors of the superior cervical ganglion of the cat. J. Pharmacol. exp. Ther.154, 426–440 (1966b).
—: Mechanism of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev.18, 629–640 (1966c).
—, andA. Jones: Facilitation of ganglionic responses after a period of preganglionic stimulation. J. Pharmacol. exp. Ther.147, 330–335 (1965).
Varagić, V.: The action of eserine on the blood pressure of the rat. Brit. J. Pharmacol.10, 349–353 (1955).
Vartiainen, A.: The action of certain new histamine derivatives. J. Pharmacol. exp. Ther.54, 265–282 (1935).
Vogt, M.: Release of medullary amines from the isolated perfused adrenal gland of the dog. Brit. J. Pharmacol.24, 561–565 (1965).
Volle, R. L.: The actions of several ganglion blocking agents on the postganglionic discharge induced by diisopropylphosphorofluoridate (DFP) in sympathetic ganglia. J. Pharmacol. exp. Ther.135, 45–53 (1962a).
—: The responses to ganglionic stimulating and blocking drugs of cell groups within a sympathetic ganglion. J. Pharmacol. exp. Ther.135, 54–61 (1962b).
—: Enhancement of postganglionic responses to stimulating agents following repetitive preganglionic stimulation. J. Pharmacol. exp. Ther.136, 68–74 (1962c).
—, andG. B. Koelle: The physiological role of acetylcholinesterase (AChE) in sympathetic ganglia. J. Pharmacol. exp. Ther.133, 223–240 (1961).
Waser, P. G.: Fehlende ganglionäre (nikotinische) Wirkungen des Muscarins. Experientia (Basel)11, 452–453 (1955).
—: Chemistry and pharmacology of mucarine, muscarone, and some related compounds. Pharmacol. Rev.13, 465–516 (1961).
Weidmann, H., u.A. Cerletti: Untersuchungen über die pressorische Wirkung des 5-Hydroxytryptamins (Serotonin). Arch. int. Pharmacodyn.111, 98–107 (1957).
Weir, M. C. L., andH. McLennan: The action of catecholamines in sympathetic ganglia. Canad. J. Biochem.41, 2627–2636 (1963).
Winbury, M. M.: Comparison of the vascular actions of 1,1-dimethyl-4-phenylpiperazinium and tetramethylammonium. J. Pharmacol. exp. Ther.124, 25–34 (1958).
Wispelaere, H. de: Actions de l'acétyl-β-méthylcholine, de l'éthyl-β-méthylcholine et de l'éthylcholine sur la circulation et sur la respiration. Arch. int. Pharmacodyn.56, 363–375 (1937).
Author information
Authors and Affiliations
Additional information
With 9 Figures
Rights and permissions
About this article
Cite this article
Trendelenburg, U. Some aspects of the pharmacology of autonomic ganglion cells. Ergebnisse der Physiologie und exper. Pharmakologie 59, 1–85 (1967). https://doi.org/10.1007/BF02269141
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02269141